This episode features Ben Merewitz, CEO and Co-founder of Agile Devices. Ben discusses the challenges faced by interventional radiologists when navigating complex anatomy with traditional microcatheters, such as difficulties in maneuvering through tortuous vessels and achieving precise target placement. Agile Devices has developed a novel, microcatheter with active tip control, called Angler, that overcomes these limitations by allowing real-time control of the tip’s shape, enabling physicians to navigate complex anatomy with greater ease and precision.
The company has received FDA clearance for the Angler and is currently conducting limited releases to gather further clinical data and demonstrate the device’s effectiveness in various interventional procedures, such as embolization. Ben highlights the importance of the Boston area’s vibrant medical device ecosystem in the development of this innovative technology and discusses the company’s future plans, including expanding into new markets and developing new applications for their deflectable technology platform. With an ‘agile’ approach, Ben’s story is sure to keep you informed and inspired.
5 Key Takeaways:
- Addressing a Critical Need: Agile Devices addresses the significant challenges faced by interventional radiologists in navigating complex anatomy with traditional microcatheters.
- Innovative Technology: The Angler microcatheter utilizes a unique, actively deflectable design that enables real-time control of the tip’s shape, improving maneuverability and precision.
- Improved Clinical Outcomes: By overcoming the limitations of traditional microcatheters, the Angler has the potential to improve procedural success rates, reduce procedure times, and minimize complications.
- Strong Ecosystem: The Boston area’s vibrant medical device ecosystem played a crucial role in the development and commercialization of the Angular.
- Future Growth: Agile Devices is expanding its product portfolio, developing new applications for its deflectable technology platform, and pursuing growth in key market segments, including neurovascular interventions.
